• 1
  • 2
    Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ 2001;11:323.
  • 3
    West S, King V, Carey T, Lohr K, McKoy N, Sutton S et al. Systems to rate the strength of evidence. Evidence, report/technology assessment. Number 47. AHRQ Publication No.02-E016. Rockville, MD: Agency for Health Care Research, 2002.
  • 4
    Bousquet J, Clark TJ, Hurd S, Khaltaev N, Lenfant C, O’Byrne P et al. GINA guidelines on asthma and beyond. Allergy 2007;62:102112.
  • 5
    Sackett DL, Rosenberg WM. The need for evidence-based medicine. J R Soc Med 1995;88:620624.
  • 6
    Elstein AS, Schwarz A. Clinical problem solving and diagnostic decision making: selective review of the cognitive literature. BMJ 2002;324:729732.
  • 7
    Barton S. Which clinical studies provide the best evidence? The best RCT still trumps the best observational study. BMJ 2000;321:255256.
  • 8
    Petticrew M, Wilson P, Wright K, Song F. Quality of Cochrane reviews. Quality of Cochrane reviews is better than that of non-Cochrane reviews. BMJ 2002;324:545.
  • 9
    Mulrow CD, Oxman AD. Cochrane collaboration handbood. Oxford: Cochrane Library. Issue 4 Update Software, 1997.
  • 10
    Mant D. Can randomised trials inform clinical decisions about individual patients? Lancet 1999;353:743746.
  • 11
    Earle CC, Weeks JC. Evidence-based medicine: a cup half full or half empty? [editorial] [in process citation]. Am J Med 1999;106:263264.
  • 12
    Herland K, Akselsen JP, Skjonsberg OH, Bjermer L. How representative are clinical study patients with asthma or COPD for a larger “real life” population of patients with obstructive lung disease? Respir Med 2005;99:1119.
  • 13
    Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA et al. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med 2004;170:836844.
  • 14
    Fairall LR, Zwarenstein M, Bateman ED, Bachmann M, Lombard C, Majara BP et al. Effect of educational outreach to nurses on tuberculosis case detection and primary care of respiratory illness: pragmatic cluster randomised controlled trial. BMJ 2005;331:750754.
  • 15
    Bousquet J, Lund VJ, Van Cauwenberge P, Bremard-Oury C, Mounedji N, Stevens MT et al. Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy 2003;58:733741.
  • 16
    Cuervo LG, Clarke M. Balancing benefits and harms in health care. BMJ 2003;327:6566.
  • 17
    Ernst E, Pittler MH. Assessment of therapeutic safety in systematic reviews: literature review. BMJ 2001;323:546.
  • 18
    Guyatt G, Vist G, Falck-Ytter Y, Kunz R, Magrini N, Schunemann H. An emerging consensus on grading recommendations. . Module 37. Topic 2011:189, 2005.
  • 19
    Carleton B, Foester V, Warren L, Smith M. Post-marketing pharmacosurveillance in Canada. A background paper prepared by the Working Conference on strengthening the evaluation of real world drug safety and effectiveness., 2005.
  • 20
    Bousquet J, Van Cauwenberge P. A critical appraisal of ‘evidence-based medicine’ in allergy and asthma. Allergy 2004;59(Suppl. 78):1220.
  • 21
    Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ 1999;318:593596.
  • 22
    Global strategy for asthma management and prevention. GINA. Update from NHLBI/WHO Workshop Report 1995, Revised 2006., 2006.
  • 23
    National Institutes of Health, National Heart, Lung and Blood Institute. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop Report. Update 2005., 2005.
  • 24
    Expert panel report 3. Guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention Program. Bethesda, MD: National Heart, Lung and Blood Institute, US Department of Health and Human Services, 2007.
  • 25
    Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;5(Suppl):S147S334.
  • 26
    Atkins D, Briss PA, Eccles M, Flottorp S, Guyatt GH, Harbour RT et al. Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res 2005;5:25.
  • 27
    Schunemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med 2006;174:605614.
  • 28
    Global Programme on Evidence for Health Policy. Guidelines for WHO Guidelines. Geneva: World Health Organization, 2003. EIP/GPE/EQC/2003.1.
  • 29
    Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490.
  • 30
    Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest 2006;129:174181.
  • 31
    Bacharier LB, Boner A, Calrsen KH, Eigenmann PA, Frischer T, Götz M et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008;63:534.
  • 32
    Brozek J, Baena-Cagnani C, Bonini S, Canonica GW, Rasi G, Gerth van Wicjk R et al. Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline. Allergy 2008.
  • 33
    Schünemann HJ, Hill S, Kakad M, Vist G, Bellamy R, Stockman L et al. WHO rapid advice guidelines for the pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis 2007;7:2131.
  • 34
    Fokkens W, Lund V, Mullol J. EP3OS. European position paper on rhinosinusitis and nasal polyps. Rhinology. 2007;45(Suppl. 20):1139.
  • 35
    Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CE, Greaves MW, Henz BM et al. EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy 2006;61:321331.
  • 36
    Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CE, Greaves MW, Henz BM et al. EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy 2006;61:316320.